Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.

Tas F., Erturk K.

Japanese journal of clinical oncology, cilt.51, ss.873-878, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1093/jjco/hyab031
  • Dergi Adı: Japanese journal of clinical oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.873-878
  • Anahtar Kelimeler: melanoma, stage III, mitotic rate, node-positive, AMERICAN JOINT COMMITTEE
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Stage III melanoma is a heterogenous disease, and the number of tumor-involved lymph nodes is the most significantly unfavorable prognostic indicator for relapse and outcome. The aim of this study is to investigate the possible effects of the various clinicopathological factors on the course of node-positive stage III disease.